Cargando…
Toxicology of Nanoparticles in Drug Delivery
Nanoparticles have revolutionized biomedicine especially in the field of drug delivery due to their intriguing properties such as systemic stability, level of solubility, and target site specificity. It can, however, be both beneficial and damaging depending on the properties in different environmen...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611175/ https://www.ncbi.nlm.nih.gov/pubmed/34840918 http://dx.doi.org/10.1007/s40139-021-00227-z |
_version_ | 1784603248231972864 |
---|---|
author | Sharma, Swati Parveen, Roza Chatterji, Biswa Prasun |
author_facet | Sharma, Swati Parveen, Roza Chatterji, Biswa Prasun |
author_sort | Sharma, Swati |
collection | PubMed |
description | Nanoparticles have revolutionized biomedicine especially in the field of drug delivery due to their intriguing properties such as systemic stability, level of solubility, and target site specificity. It can, however, be both beneficial and damaging depending on the properties in different environments, thus highlighting the importance of nanotoxicology studies before use in humans. Different types of nanoparticles have been used in drug delivery, and this review summarizes the recent toxicity studies of these nanoparticles. The toxicological evaluation of three widely used nanoparticles in drug delivery that are metal, lipid, and protein nanoparticles has been discussed in detail. Studies have recorded several toxic effects of various nanoparticles such as metal-based nanoparticles have been linked to increased oxidative stress and have the potential to infiltrate the cell nucleus and protein-based nanoparticles have been observed to have hepatotoxicity and nephrotoxicity as their adverse effects. Considering the increasing application of nanoparticles in drug delivery and the growing concerns of regulatory authorities regarding the toxicity of nanocarriers in living organisms, it requires urgent attention to identify the gap in toxicity studies. The review highlights the gap in toxicity studies and potential focus areas to overcome the existing challenges. |
format | Online Article Text |
id | pubmed-8611175 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-86111752021-11-24 Toxicology of Nanoparticles in Drug Delivery Sharma, Swati Parveen, Roza Chatterji, Biswa Prasun Curr Pathobiol Rep Nanoparticle-Based Drug Delivery (M Gogoi, Section Editor) Nanoparticles have revolutionized biomedicine especially in the field of drug delivery due to their intriguing properties such as systemic stability, level of solubility, and target site specificity. It can, however, be both beneficial and damaging depending on the properties in different environments, thus highlighting the importance of nanotoxicology studies before use in humans. Different types of nanoparticles have been used in drug delivery, and this review summarizes the recent toxicity studies of these nanoparticles. The toxicological evaluation of three widely used nanoparticles in drug delivery that are metal, lipid, and protein nanoparticles has been discussed in detail. Studies have recorded several toxic effects of various nanoparticles such as metal-based nanoparticles have been linked to increased oxidative stress and have the potential to infiltrate the cell nucleus and protein-based nanoparticles have been observed to have hepatotoxicity and nephrotoxicity as their adverse effects. Considering the increasing application of nanoparticles in drug delivery and the growing concerns of regulatory authorities regarding the toxicity of nanocarriers in living organisms, it requires urgent attention to identify the gap in toxicity studies. The review highlights the gap in toxicity studies and potential focus areas to overcome the existing challenges. Springer US 2021-11-24 2021 /pmc/articles/PMC8611175/ /pubmed/34840918 http://dx.doi.org/10.1007/s40139-021-00227-z Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Nanoparticle-Based Drug Delivery (M Gogoi, Section Editor) Sharma, Swati Parveen, Roza Chatterji, Biswa Prasun Toxicology of Nanoparticles in Drug Delivery |
title | Toxicology of Nanoparticles in Drug Delivery |
title_full | Toxicology of Nanoparticles in Drug Delivery |
title_fullStr | Toxicology of Nanoparticles in Drug Delivery |
title_full_unstemmed | Toxicology of Nanoparticles in Drug Delivery |
title_short | Toxicology of Nanoparticles in Drug Delivery |
title_sort | toxicology of nanoparticles in drug delivery |
topic | Nanoparticle-Based Drug Delivery (M Gogoi, Section Editor) |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611175/ https://www.ncbi.nlm.nih.gov/pubmed/34840918 http://dx.doi.org/10.1007/s40139-021-00227-z |
work_keys_str_mv | AT sharmaswati toxicologyofnanoparticlesindrugdelivery AT parveenroza toxicologyofnanoparticlesindrugdelivery AT chatterjibiswaprasun toxicologyofnanoparticlesindrugdelivery |